Semantic Coherence: Elekta – Signal Evidence & AI Readability

[H1] Nobody doesadaptivelike Elekta
Adaptive radiotherapy is changing what’s possible in cancer treatment.Elekta is making it work in routine clinical practice, combining precision, workflow and evidence to help centers deliver adaptive care as a new standard.Adaptive Radiotherapy
Your browser does not support HTML video..
[IMG: Iconographic - More than 930K people diagnosied each year]
[H2] Head and neck cancer
Around 75% of patients with head and neck cancer benefit from radiotherapy during the course of their disease, making access to precision treatment critical.Read more
[IMG: Iconographic - 87% of breast cancer patients should receive radiotherapy]
[H2] Breast cancer
Every breast cancer case presents its own challenges, from daily anatomical changes to protecting the heart and lungs. Radiotherapy plays a vital role across all stages of breast cancer.Read more
[IMG: Iconographic - More than 430K people affected each year]
[H2] Kidney cancer
For patients who cannot have surgery, radiotherapy provides a non-invasive option with curative potential that helps preserve kidney function and reduce dose to the bowel and liver.Read more
[IMG: Iconographic - More than 320K people affected each year]
[H2] Brain tumors
Protect cognition, memory, and vision in brain tumor treatment. Evidence shows how imaging and adaptive precision help preserve function and quality of life.Read more
[IMG: Iconographic - globally 1.47M diagnoses each year]
[H2] Prostate cancer
Shorter courses, greater precision, preserved function. Clinical evidence shows how daily adaptation improves accuracy and long-term outcomes.Discover more
[IMG: Iconographic - incidence is expected to rise by over 70% by 2040]
[H2] Gynecological cancers
Treating gynecological cancers requires precision and care. Image-guided radiotherapy and brachytherapy adapt to pelvic changes while protecting healthy tissue.Learn more
[IMG: Iconographic - globally only 10% people survive five years]
[H2] Pancreatic cancer
Evidence shows how adaptive radiotherapy can deliver high-dose treatment safely and extend survival, offering new hope in one of the hardest cancers to treat.Explore the research
[H2] Adaptive radiotherapy
The new standard of careFor more than 50 years, Elekta has advanced precision in cancer care. Now we’re leading the way in making adaptive radiotherapy a practical standard of care for clinics everywhere.Find out more
[H2] Where every difference counts
From small changes in a tumor to complex clinical decisions, Elekta helps clinicians respond with precision and confidence, advancing the standard of care in radiotherapy.About us
[H2] Making a difference together
[IMG: Kerry by Elekta Evo]
[H4] Precision treatment helped Kerry to focus on the future instead of …
Mar 20, 2026
3 minute
read
[IMG: Lucia Bianco]
[H4] Lucia found hope and healing with Leksell Gamma Knife
Feb 24, 2026
3 minute
read
[IMG: Harry Branson]
[H4] Harry received the treatment, and response, both he and his urologist …
Feb 3, 2026
3 minute
readMore articles
[H2] Press Releases
More press releases
[IMG: Smiling coworkers connecting with each other]
[H2] Choose a career with us
[H3] We don't just build technology,we build hope
Careers at Elekta

[IMG: About Elekta | Precision Radiation Medicine | Elekta hero]
[H1] About us
Where every difference countsEach year, millions of people hear the words no one wants to hear: "You
have cancer." And behind each diagnosis lies a unique story, a family that
deserves hope, a future that's worth fighting for.We know that no two treatment journeys are the same and delivering care is
far from simple. It's complex, urgent, and deeply human. That’s why we
don’t back down from challenges—we rise to them. From the smallest tumor
change to the toughest clinical decisions, we see every obstacle as an
opportunity to progress.That is what drives us. The people undergoing treatment. The clinicians
providing the care. We are united in purpose.Together, we can create a world where every patient has access to the
highest standard of care. This is our commitment because for everyone,
it's personal.We are leading the innovation in personalized radiation therapy solutions. We
are Elekta.With you. For a world of difference.
[H3] Board of Directors
[H3] Executive Committee
[H3] Sustainability
[H3] Careers
[H3] Story
[H3] Values
[H3] Risk management

[IMG: Global Careers | View Open Job Positions & Apply | Elekta hero]
[H1] Careers at Elekta
We don't just build technology, we build hope
[H2] Build your career with us!
Explore Open Positions
Job Sectors
[H2] We are passionate about what we do
Imagine working for a company where everyone strives to bring hope to
people living with cancer. We are passionate about what we do and as
part of Elekta, you are part of a journey towards a world where everyone
has access to the best cancer care.To us, cancer is personal, and we want to make a difference for everyone
who is impacted. That's why we need more people, just like you, to help
us make a difference to cancer patients, their loved ones and clinicians
using our technology to make a difference where it really matters.
[H2] Explore our open positions in many different areas
[H3] Sales
[H3] Services
[H3] Operations
View all open positions
[H3] or stay up to date & sign up for job alerts
Sign up
Discover Elekta
[H2] Hope for everyone dealing with cancer
As a leader in precision radiation therapy solutions and personalized
radiotherapy treatments, Elekta is committed to ensuring that every
patient has access to the best cancer care possible.Read More About Us
Why Elekta
[H2] Elekta offers unlimited opportunities
[H3] Work for a higher purpose
Hope for everyone dealing with cancer
[H3] International opportunities
Elekta is a company with global reach
[H3] Acquire diverse skill set
Elekta allows for opportunities across many areas
[H3] Learn and develop
People development is at the top of the strategic agenda
[H3] Greater responsibility, faster
Elekta's small scale allows for quick career advancement
Life at Elekta
[H2] Life at Elekta
A Culture of Innovation and CollaborationOn this page, you'll discover what Life At Elekta is all about. We create an environment where innovation and collaboration thrive, with every team member playing a vital role in our mission to improve cancer care through advanced technology. Hear from our colleagues about their experiences, the impact they make, and how they contribute to shaping the future of healthcare.Learn more
Working Approach
[H2] Ways of working
The way we work impacts how we feel, how productive we are and in the
end, the overall success of our company. Our ways of working are firmly
rooted in the culture we create, our purpose, and our values.Flexibility is an overarching concept for our ways of working. We want
you to experience a balance between your home and your Elekta office. We
recognize that a flexible work environment is valued and trust you to
use it to generate great results.
[IMG: people at table]
Culture & Values
[H2] Culture and values
[H3] We work as one team
We work collaboratively and inclusively. Only then can we truly focus on
getting things done for our customers and their patients.
[H3] We do what we say
We act with accountability and integrity, taking personal and collective
responsibility for making the right things happen.
[H3] We keep thinking forward
Our innovative spirit and resourcefulness keep us ahead of the game. We
refine our approach to be the most efficient and effective.Our values are about us. It's HOW we do business - the Elekta way. Our
values unite us as a company, making it possible for you to succeed no
matter where you are in the organization.
Pink Ribbon Challenge
[H2] The Pink Ribbon Challenge
At Elekta, we prioritize maintaining a healthy work-life balance and
believe staying active contributes to mental well-being, personal
development, and professional growth. Our Pink Ribbon Challenge is a
global initiative that aligns with our fundamental principles, promoting
inclusivity, teamwork, and community involvement. Our employees
collaborate as a team, working on this worldwide project while carrying
out local activities to raise funds for the Elekta Foundation, which
provides screening services for women facing breast or cervical cancer.
Together, we significantly impact the lives of those affected by cancer
while exemplifying our core values every step of the way.Read more about The Pink Ribbon Challenge
Inspiring Growth
[H2] An inspiring place to grow
People are the core of our business. Whether they are patients,
partners, or our 4,700-strong workforce, it's all about people. Getting
the right employees to build a career with us is essential for our
success. You can develop in a multitude of ways, and our aim is to
create a culture and workplace where you can grow professionally as well
as personally.Read more about Elekta's culture
Inclusion
[H2] Diversity, inclusion and belonging
At Elekta, we are dedicated to bringing hope to everyone dealing with
cancer.To drive this, we believe in creating an
inclusive workplace where our people can be their
authentic selves and
feel like they belong and work to their full potential.We are convinced that this helps
fuel a culture of innovation and high performance,
where employees are empowered to
work towards a world where everyone has access to the best cancer
care.At Elekta, we are on a continuous journey of fostering diversity
and inclusion. We are making strides in our D&I initiatives, and
with the recent launch of D&I leads in each organizational unit
we are one step closer to embedding it in everything that we do.Jean JönssonDirector Diversity, Inclusion and Culture
[IMG: Careers]
International Careers
[H2] Our global presence -your international career
Sustainability
[H2] Sustainability is our responsibility
What we do matters, but how we do it matters more than ever.As a global company, we have global responsibilities not just to our
shareholders, customers, and employees, but to the communities we work
in, and the world we leave behind for future generations.Conducting a business sustainably and responsibly is not a matter of
choice anymore. It is a must and an integral element to any company's
success. It is therefore the foundation for Elekta's overall strategy
and integrated in everything we do.Read more about our sustainability work
Equal Opportunities
[H2] We are an equal opportunity employer
This means we evaluate qualified applicants without regard to race,
color, religion, sex, sexual orientation, gender identity, genetic
information, national origin, disability, veteran status, or any other
protected characteristic.
[H3] Reasonable Accommodations, US specific
Elekta is committed to complying fully with the Americans with
Disabilities Act (ADA) and other applicable federal, state, and local
laws. We are also committed to ensuring equal opportunity in employment
for qualified persons with disabilities. We make our employment
decisions based on the merits of the situation in accordance with
defined criteria, not the disability of the individual. Furthermore, the
Company is committed to not discriminating against any qualified
employee or applicant because the person is related to or associated
with a person with a disability.Should you require reasonable accommodations during the job application
process, please contact us via e-mail at:
recruitingna@elekta.com or
via mail to the following address:Attention: Human Resources Dept.Re: Reasonable AccommodationsElekta, Inc.400 Perimeter Center TerraceAtlanta, GA 30346
[H2] Follow Elekta
[IMG: Facebook]
[IMG: LinkedIn]
[IMG: X]
[IMG: Instagram]
[IMG: Youtube]
[IMG: glassdoor]
[H2] Join us now
View Open Positions

[H1] Adaptive Radiotherapy
The new standard of careFor more than 50 years, Elekta has advanced precision in cancer care. Now we’re leading the way in making adaptive radiotherapy a practical standard of care for clinics everywhere.Get in touch
Watch video
[H2] What is Adaptive Radiotherapy?
Adaptive Radiotherapy (also known as ART or Adaptive Radiation Therapy) adjusts treatment to each patient’s unique anatomy and response.At Elekta, in collaboration with our clinical partners we're delivering both CT and MR imaging with intelligent workflows, real-time decision support, and precise dose delivery—so you can adapt treatment with confidence.There are two main ways of adapting treatment plans—whilst the patient is on the bed (Online) or between treatment sessions (Offline). Both allow clinicians to deliver radiation more precisely whilst taking into account for daily changes in anatomy, tumor position, or organ motion.Online Adaptive therapyPlan recalculation to account for changes between the approved plan and the patient’s current anatomy or delivered dose, while the patient is on the treatment table.Offline adaptive therapyPlan recalculation between fractions (interfraction), based on imaging and clinical review from an earlier session. Also called re-planning.
[H2] Adaptive is more than technology—it’s a way of rethinking precision
With Elekta, seeing clearly means treating precisely. And treating precisely means every patient gets the right care, at the right moment.
[H3] The case for adaptive radiotherapy
Daily anatomy shifts are realUp to 90% of adapted fractions need plan changes in prostate and pancreas cases.1Fewer sessions, same or better outcomesAdaptive makes 2–5 fraction hypofractionation feasible.2Margins matterUNITED trial shows MRI-guided ART reduces margins safely in high-grade gliomas.3Toxicity can be reducedMIRAGE trial showed a 5× reduction in GU toxicity with adaptive.4Hope for pancreas patientsAdaptive SBRT is extending survival and improving local control in a historically lethal disease.5Global need is growing35M cancer cases projected annually by 2050 demand smarter delivery.6
[H2] Adaptive in action
Clinicians at Mary Bird Perkins Cancer Center and AdventHealth show how Elekta’s adaptive technologies are transforming care in practice. From reducing treatment sessions with Elekta Unity in Baton Rouge to advancing precision brain treatments with Leksell Gamma Knife® in Orlando, adaptive is changing the experience for patients every day.
[H2] The benefits of Adaptive Radiotherapy
[H3] Clinical confidence
Greater precision, better outcomesPlans reflect each patient’s daily anatomy, reducing toxicity, protecting organs at risk, and enabling safe dose escalation with evidence of improved outcomes.MIRAGE trial — prostate SBRT, MRI guidance reduced GU toxicity ~5x vs CTUNITED trial — high-grade gliomas, showed safe margin reduction & dose escalationPer Pfeiffer et al., — MR-guided SBRT produced better survival rates than conventional methods for locally advanced pancreatic cancer.
[H3] Operational pressures
Improved efficiency, agile workflowsHypofractionated schedules (2–5 fractions) free up capacity, while adaptive workflows streamline complex cases without overburdening staff.MIRAGE — validated feasibility of 5-fraction schedules in prostateHERMES trial— MRgRT enables higher dose treatment whilst maintaining outcomes, effectively increasing throughout.de Leon et al. —MRgRT may eliminate the need for separate simulation sessions
[H3] Financial & strategic value
Lower costs, higher valueFewer treatment sessions mean lower costs for patients and payers whilst increasing patient throughput.With <8.4m more patients needing radiotherapy by 2050, the demand will increase for advanced treatment modalities that offer higher precision.Chuong et al., 2023—hypofractionation reduces number of visits, lowering travel and co-pay burden while freeing machine capacityHypofractionated adaptive radiotherapy enables the treatment of previously inoperable or high-risk tumors
[H2] Clinical evidence that matters
Together with leading cancer centers worldwide, Elekta has built one of the strongest bodies of adaptive evidence in the field. These studies demonstrate that adaptive radiotherapy is no longer an experiment—it’s becoming a standard of care.
[H3] Dr. Lampe
"Adaptive opens up a totally new world for us. We can see what we’re treating—and adapt to it."
[H3] Why radiotherapy is key to transforming cancer care
Prof. Pat Price on Spilling the RT
[H3] EMBRACE studies show improved local control and reduced morbidity
[H3] CBCT + HDMM validated for adaptive SRS with <1 mm error
[H3] MOMENTUM trial
[H3] UNITED trial
[H3] Hypothesis Testing Program
[H3] See more studies
[H2] Share your thoughts
We're asking how centers are approaching adaptive radiotherapy, where are you on the journey?1. Why are you interested in content on adaptive radiotherapy? To enhance how we currently use it To prepare for implementation within 6 months To prepare for implementation within 12–24 months For general interest - increase awareness/ knowledge onlyNext2. Where are you based? North America Europe Asia-Pacific Latin America Middle East & AfricaNextBackThank you for completing the surveyIf you want to learn more about adaptive radiotherapy click the button below.Get in touchBack
[H2] Evolve your standard of care—one step at a time
Clinics worldwide are delivering care that adapts—combining technology, insight, and compassion to meet patients where they are.Whether you’re refining margins, adopting daily imaging, scaling your workflow or expanding into new capabilities, Elekta is here to support your next step.Leading clinicians in India explain how adaptive radiotherapy personalizes treatment to daily patient changes, helping reduce side effects and improve outcomes.
[H2] You don’t have to do it alone
Adaptive is a journey, and we're here to support you at every stage. With multi-modality imaging, software, and expert guidance, we help make adaptive work for your clinic—so every patient receives the right treatment at the right moment, tailored to their unique anatomy and response.Adaptive is the future of personalized care, and nobody does adaptive like Elekta.Talk to an Elekta specialist
[H2] Indications
ProstatePancreasGynecologicalBrainKidneyBreastHead and neckReferencesMomentum Registry, IJROBP 2022
https://clinicaltrials.gov/study/NCT04075305PACE-B Trial, Lancet Oncol 2023
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00517-4/fulltextUNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3) (UNITED-3)
https://clinicaltrials.gov/study/NCT05720078MIRAGE Trial, JCO2023
https://pubmed.ncbi.nlm.nih.gov/36633877/SMART Trial, Phase II, 2023
https://www.redjournal.org/article/S0360-3016(23)00499-6/fulltext
https://doi.org/10.1016/j.ijrobp.2023.05.023Global Impact Report, 2025
aboutadaptive.com